Collegium Pharmaceutical expands board with new director
STOUGHTON, Mass. - Collegium Pharmaceutical , Inc. (NASDAQ:COLL), a diversified biopharmaceutical company with a market capitalization of nearly $1 billion and impressive gross profit margins of 87%, ...
Collegium appoints Nancy Lurker to board of directors
Collegium Pharmaceutical (COLL) announced the appointment of Nancy Lurker to its Board of Directors, effective February 4, 2025. Lurker most ...
Collegium Appoints Nancy S. Lurker to its Board of Directors
STOUGHTON, Mass., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced the appointment of Nancy S. Lurker to its Board of Directors, effective February 4, ...
China Universal Asset Management Co. Ltd. Grows Stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)
China Universal Asset Management Co. Ltd. boosted its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) ...
American Association of Individual Investors2d
3 Undervalued Pharmaceuticals Stocks for Monday, February 03
Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued ...